Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2074-2083

  Ramón García, Santiago ^a,b,c   Mick, Virginie ^a,b   Dainese, Elisa ^d   Martín, Carlos ^a,b   Thompson, Charles J ^c   De Rossi, Edda ^e   Manganelli, Riccardo ^d   Aínsa, José A ^a,b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2' N ETHYLNETILMICIN; 6' N ETHYLNETILMICIN; ACRIFLAVINE; AMINOSALICYLIC ACID; BCG VACCINE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORAMPHENICOL; CLARITHROMYCIN; ETHAMBUTOL; GENTAMICIN; ISONIAZID; PEPTIDOGLYCAN; RIFAMPICIN; SPECTINOMYCIN; STREPTOMYCIN; TETRACYCLINE; TRICLOSAN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; CELL FUNCTION; CELL GROWTH; CELL MUTANT; CELL STRUCTURE; DOWN REGULATION; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRAIT; MYCOBACTERIUM BOVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION;

ACRIFLAVINE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BENZOPHENONEIDUM; BLOTTING, SOUTHERN; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUORESCENT DYES; GENES, TRANSGENIC, SUICIDE; MEMBRANE TRANSPORT PROTEINS; MICROARRAY ANALYSIS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; PLASMIDS; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; TETRACYCLINE; UNCOUPLING AGENTS;

EID: 84858671542     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05946-11     Document Type: Article

References (64)

1. Adams KN, et al. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145:39-53.
2. Ainsa JA, et al. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J. Bacteriol. 180:5836-5843. (Pubitemid 28514198)
3. Boguski MS, Mandl KD, Sukhatme VP. 2009. Drug discovery. Repurposing with a difference. Science 324:1394-1395.
4. Brosch R, et al. 2000. Comparative genomics uncovers large tandem chromosomal duplications in Mycobacterium bovis BCG Pasteur. Yeast 17:111-123. (Pubitemid 30466089)
5. Camacho LR, et al. 2001. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276:19845-19854.
6. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-267. (Pubitemid 29486244)
7. Crick DC, Mahapatra S, Brennan PJ. 2001. Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 11:107R-118R. (Pubitemid 32976343)
8. De Rossi E, Ainsa JA, Riccardi G. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36 -52.
9. De Rossi E, et al. 2002. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol. Med. 8:714-724. (Pubitemid 36337498)
10. De Rossi E, et al. 1998. Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob. Agents Chemother. 42:1931-1937. (Pubitemid 28363072)
11. Dhamdhere G, Zgurskaya HI. 2010. Metabolic shutdown in Escherichia coli cells lacking the outer membrane channel TolC. Mol. Microbiol. 77: 743-754.
12. Dziadek J, Madiraju MV, Rutherford SA, Atkinson MA, Rajagopalan M. 2002. Physiological consequences associated with overproduction of Mycobacterium tuberculosis FtsZ in mycobacterial hosts. Microbiology 148:961-971. (Pubitemid 34436773)
13. Escolar L, Perez-Martin J, de Lorenzo V. 1999. Opening the iron box: transcriptional metalloregulation by the Fur protein. J. Bacteriol. 181: 6223-6229. (Pubitemid 29512928)
14. Fange D, Nilsson K, Tenson T, Ehrenberg M. 2009. Drug efflux pump deficiency and drug target resistance masking in growing bacteria. Proc. Natl. Acad. Sci. U. S. A. 106:8215-8220.
15. Farrow MF, Rubin EJ. 2008. Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J. Bacteriol. 190:1783-1791. (Pubitemid 351304034)
16. Fraud S, Poole K. 2011. Oxidative stress induction of the MexXY multi-drug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55: 1068-1074.
17. Geiman DE, Raghunand TR, Agarwal N, Bishai WR. 2006. Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB-like genes. Antimicrob. Agents Chemother. 50:2836-2841. (Pubitemid 44198709)
18. Gey Van Pittius NC, et al. 2001. The ESAT-6 gene cluster of Mycobacterium tuberculosis and other high G+C Gram-positive bacteria. Genome Biol. 2:RESEARCH0044.
19. Heym B, Zhang Y, Poulet S, Young D, Cole ST. 1993. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J. Bacteriol. 175:4255-4259. (Pubitemid 23206923)
20. Jiang X, et al. 2008. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb. Drug Resist. 14:7-11. (Pubitemid 351441845)
21. Kadner RJ, Murphy GP, Stephens CM. 1992. Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J. Gen. Microbiol. 138:2007-2014.
22. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. (Pubitemid 47332566)
23. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. 2011. The challenge of new drug discovery for tuberculosis. Nature 469:483-490.
24. Krulwich TA, Lewinson O, Padan E, Bibi E. 2005. Do physiological roles foster persistence of drug/multidrug-efflux transporters? A case study. Nat. Rev. Microbiol. 3:566-572. (Pubitemid 40903879)
25. Lau SY, Zgurskaya HI. 2005. Cell division defects in Escherichia coli deficient in the multidrug efflux transporter AcrEF-TolC. J. Bacteriol. 187: 7815-7825. (Pubitemid 41587718)
26. Li XZ, Nikaido H. 2009. Efflux-mediated drug resistance in bacteria: an update. Drugs 69:1555-1623.
27. Lomovskaya O, et al. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. (Pubitemid 32039101)
28. Louw GE, et al. 2011. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Am. J. Respir. Crit. Care Med. 184:269-276.
29. Louw GE, et al. 2009. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 53:3181-3189.
30. Maciag A, et al. 2007. Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon. J. Bacteriol. 189:730-740. (Pubitemid 46183847)
31. Manganelli R, Dubnau E, Tyagi S, Kramer FR, Smith I. 1999. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol. Microbiol. 31:715-724. (Pubitemid 29046111)
32. Manganelli R, et al. 2004. The extra cytoplasmic function sigma factor sigma(E) is essential for Mycobacterium tuberculosis virulence in mice. Infect. Immun. 72:3038 -3041.
33. Manganelli R, Provvedi R. 2010. An integrated regulatory network including two positive feedback loops to modulate the activity of sigma(E) in mycobacteria. Mol. Microbiol. 75:538-542.
34. Manganelli R, Voskuil MI, Schoolnik GK, Smith I. 2001. The Mycobacterium tuberculosis ECF sigma factor sigma(E): role in global gene expression and survival in macrophages. Mol. Microbiol. 41:423-437. (Pubitemid 32730541)
35. McMurry L, Petrucci RE, Jr, Levy SB. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 77:3974 -3977.
36. Milano A, et al. 2009. Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system. Tuberculosis (Edinb.) 89:84-90.
37. Morris RP, et al. 2005. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 102:12200 -12205.
38. Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T. 2004. Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb.) 84:239-246. (Pubitemid 38857856)
39. Narberhaus F. 1999. Negative regulation of bacterial heat shock genes. Mol. Microbiol. 31:1-8. (Pubitemid 29012142)
40. Newton GL, Ta P, Bzymek KP, Fahey RC. 2006. Biochemistry of the initial steps of mycothiol biosynthesis. J. Biol. Chem. 281:33910-33920. (Pubitemid 46036603)
41. Nikaido H. 2009. Multidrug resistance in bacteria. Annu. Rev. Biochem. 78:119-146.
42. Nishino K, Nikaido E, Yamaguchi A. 2009. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim. Biophys. Acta 1794:834-843.
43. Parish T, Stoker NG. 1998. Mycobacterial protocols. In Parish T, Stoker NG (ed), Methods in molecular biology, vol 101. Humana Press, Totowa, NJ.
44. Parish T, Stoker NG. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146:1969 -1975.
45. Pavelka MS, Jr, Jacobs WR, Jr. 1996. Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis. J. Bacteriol. 178:6496-6507.
46. Piddock LJ. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382-402.
47. Piddock LJ. 2006. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 4:629-636. (Pubitemid 44317025)
48. Plumbridge J. 2009. An alternative route for recycling of N-acetylglucosamine from peptidoglycan involves the N-acetylglucosamine phosphotransferase system in Escherichia coli. J. Bacteriol. 191:5641-5647.
49. Prentki P, Krisch HM. 1984. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29:303-313. (Pubitemid 14038235)
50. Raman S, et al. 2001. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J. Bacteriol. 183:6119-6125. (Pubitemid 32917431)
51. Ramon-Garcia S, Martin C, Ainsa JA, De Rossi E. 2006. Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum. J. Antimicrob. Chemother. 57:252-259. (Pubitemid 43160166)
52. Ramon-Garcia S, Martin C, De Rossi E, Ainsa JA. 2007. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J. Antimicrob. Chemother. 59:544-547. (Pubitemid 47073463)
53. Ramon-Garcia S, Martin C, Thompson CJ, Ainsa JA. 2009. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob. Agents Chemother. 53:3675-3682.
54. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
55. Siddiqi N, et al. 2004. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32:109-111. (Pubitemid 38457104)
56. Soliveri JA, Gomez J, Bishai WR, Chater KF. 2000. Multiple paralogous genes related to the Streptomyces coelicolor developmental regulatory gene whiB are present in Streptomyces and other actinomycetes. Microbiology 146:333-343. (Pubitemid 30099208)
57. Stewart GR, et al. 2005. The stress-responsive chaperone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis. Mol. Microbiol. 55:1127-1137. (Pubitemid 40299182)
58. Stewart GR, et al. 2002. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 148: 3129-3138. (Pubitemid 35243712)
59. Sweetman SC, ed. 2011. Martindale: the complete drug reference. Pharmaceutical Press, London, United Kingdom.
60. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121. (Pubitemid 32397092)
61. van Heijenoort J. 2001. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 11:25R-36R.
62. Vaquerizas JM, et al. 2005. GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res. 33: W616-W620. (Pubitemid 44529996)
63. Voskuil MI, Visconti KC, Schoolnik GK. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and lowoxygen dormancy. Tuberculosis (Edinb.) 84:218-227. (Pubitemid 38857854)
64. Wilkinson KA, et al. 2005. Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2. J. Immunol. 174:4237-4243. (Pubitemid 40396004)